Return to homepagePandemic Pact

Defining the disease course and immune profile of COVID-19 in the immunosuppressed patient (DeCOmPRESS study)

  • Funded by HRB Ireland, Irish Research Council
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $235,891.44

  • Funder

    HRB Ireland, Irish Research Council

  • Principal Investigator

    Professor Mark Little

  • Research Location

    Ireland

  • Lead Research Institution

    Trinity College Dublin

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The DECOMPRESS project will determine the outcome of patients taking immunosuppressive medication who contract COVID 19. This will allow us to target accurate advice regarding cocooning to these patients, and to inform development of new therapies and biomarkers